je.st
news
Tag: fda
U.S. FDA approves Orexo drug to treat opioid addiction
2013-07-04 21:12:00| Appliances - Topix.net
The U.S. Food and Drug Administration has approved Swedish drugmaker Orexo AB's drug to treat opioid addiction, the company said on Thursday, sending its shares up as much as 14.3 percent in Stockholm.
Tags: drug
treat
addiction
fda
FDA grants priority review to Roche's leukemia drug
2013-07-03 10:36:06| Biotech - Topix.net
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.
Tags: review
drug
priority
grants
TPR Tubing is Available in Industrial and FDA Grades
2013-07-02 06:00:00| Chemical Processing
New Age Industries manufactures Suprene thermoplastic rubber (TPR) tubing in two hardnesses Shore 64A and 80A and in two grades: FDA and industrial. The tubings applications include food and beverage transfer, flavor and additive dispensing, fluid transfer in appliances, chemical lines, pharmaceutical processing, agriculture and lawn equipment, ink...
Tags: industrial
grades
fda
tubing
FDA Approves New U.S. Labeling for ISENTRESS (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients
2013-07-01 23:05:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved new labeling for ISENTRESS (raltegravir) Film-coated Tablets, Mercks integrase inhibitor for the treatment of HIV-1 infection in adult patients as part of combination HIV therapy. Language: English Contact: MerckMedia Contacts:Caroline Lappetito, 267-305-7639Claire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
include
study
adult
Merck: FDA wants more studies of insomnia drug
2013-07-01 17:49:01| Biotech - Topix.net
Drugmaker Merck & Co. says federal regulators have ruled that they won't approve high doses of its experimental insomnia medication because of concerns about their safety.
Sites : [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] next »